Welcome back to another episode of "Tear It Apart." I'm Donny Mack, and today we're diving into a fascinating and critical topic: Phenylketonuria, or PKU. This genetic disorder has a significant impact on those who live with it, and understanding PKU is crucial for raising awareness and supporting those affected. So, let's get into the details of what PKU is, its origins, how it's managed, and the challenges it presents. Phenylketonuria, commonly known as PKU, is a rare genetic disorder that affects about 1 in 10,000 to 15,000 newborns in the United States. It was first identified in 1934 by a Norwegian doctor named Asbjørn Følling. Dr. Følling discovered the condition when he noticed a peculiar odor in the urine of two siblings with intellectual disabilities. He determined that the cause was an accumulation of phenylpyruvic acid, a breakdown product of the amino acid phenylalanine, in their bodies. This discovery marked the beginning of our understanding of PKU. PKU is caused by a mutation in the PAH gene, which provides instructions for making an enzyme called phenylalanine hydroxylase. This enzyme is responsible for breaking down phenylalanine, an amino acid found in many protein-containing foods. When the PAH gene is mutated, the enzyme either doesn't work properly or is completely absent. As a result, phenylalanine builds up in the blood and other tissues, leading to a variety of health problems. Phenylalanine is an essential amino acid, meaning our bodies need it to function properly, but we can't produce it ourselves. We get phenylalanine from our diet, particularly from high-protein foods like meat, eggs, dairy products, nuts, and some artificial sweeteners. In individuals with PKU, consuming these foods can lead to dangerous levels of phenylalanine in the blood, which can cause brain damage and other serious health issues if left untreated. Newborn screening for PKU is a standard practice in many countries, including the United States. The test, often referred to as the Guthrie test, involves taking a small blood sample from the baby's heel within the first few days of life. This early detection is crucial because starting treatment immediately can prevent the severe consequences of untreated PKU, such as intellectual disabilities, seizures, and behavioral problems. Managing PKU primarily involves a strict diet low in phenylalanine. This means avoiding high-protein foods and using special medical formulas and low-protein products to meet nutritional needs. The diet must be carefully monitored and adjusted throughout life, particularly during periods of rapid growth, such as infancy, childhood, and pregnancy. This dietary management can be challenging and requires ongoing support from healthcare providers, dietitians, and family members.